COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Prevalence of Mullerian Anomalies in Infertile Women

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03498079
Recruitment Status : Recruiting
First Posted : April 13, 2018
Last Update Posted : January 9, 2019
Kasr El Aini Hospital
National Research Center, Egypt
misr Infertility centre ,Alaqsor
Information provided by (Responsible Party):
Mahmoud Alalfy, Aljazeera Hospital

Brief Summary:
  • Mullerian anomalies are congenital structural anomalies in the uterus .
  • Its prevalence is not uncommon .

Condition or disease Intervention/treatment
Mullerian Anomaly of Uterus Diagnostic Test: 3D ultrasound

Detailed Description:
  • PCO is very common in gynecological practice
  • Women with mullerian anomalies should be properly evaluated for other gynecological and urological problems

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 250 participants
Observational Model: Other
Time Perspective: Prospective
Target Follow-Up Duration: 4 Weeks
Official Title: Prevalence of Mullerian Anomalies and PCO in Egyptian Women
Actual Study Start Date : April 16, 2018
Estimated Primary Completion Date : April 20, 2019
Estimated Study Completion Date : April 25, 2019

Intervention Details:
  • Diagnostic Test: 3D ultrasound
    3D ultrasound will be done to females complaining from primary infertility with mullerian anomalies

Primary Outcome Measures :
  1. the number of participants who will prove to have PCO [ Time Frame: within 4 weeks ]
    diagnosis of PCO by US and by FSH and LH levels

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   20 Years to 40 Years   (Adult)
Sexes Eligible for Study:   Female
Gender Based Eligibility:   Yes
Gender Eligibility Description:   females with primary infertility
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
- females with age between 20-42 years with primary infertility

Inclusion Criteria:

  • females with age between 20-42 years with primary infertility

Exclusion Criteria:

  • females with age above 42 years or below 20 years females with secondary infertility

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT03498079

Layout table for location contacts
Contact: Mahmoud Alalfy 01002611058

Layout table for location information
Algazeerah Recruiting
Giza, Egypt
Contact: Mahmoud Alalfy, master    +201002611058   
Contact: Ahmed Elgazzar, M.D    +201014005959      
Principal Investigator: Mahmoud Alalfy, master         
Sponsors and Collaborators
Aljazeera Hospital
Kasr El Aini Hospital
National Research Center, Egypt
misr Infertility centre ,Alaqsor
Layout table for investigator information
Principal Investigator: Mahmoud Alalfy Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt

Additional Information:

Layout table for additonal information
Responsible Party: Mahmoud Alalfy, Assistant Researcher , National Research centre and Specialist of Obstetrics and Gynecology in Aljazeerah hospital, Aljazeera Hospital Identifier: NCT03498079    
Other Study ID Numbers: mullerian anomalies
First Posted: April 13, 2018    Key Record Dates
Last Update Posted: January 9, 2019
Last Verified: January 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: we will publish the results which will be obtained from this study

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Congenital Abnormalities